Results

Total Results: 405 records

Showing results for "disorder".

221. New Tool Helps Manage Opioid Use in Older Adults | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/898.html
     January 01, 2024 - healthcare systems to improve opioid medication management and prevent opioid misuse and opioid use disorder

222. Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
     February 01, 2020 - ; others are concerned that families will feel blamed; fear that discussion will trigger an eating disorder … Blount disease (tibia vara): Another skeletal disorder associated with childhood obesity.

223. CHIPRA Measure 240: Parent Report of Discussion of Weight Concerns for Child (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-240-bmi-parent-full-report.pdf
     February 01, 2020 - stigmatized; they are concerned that parents will feel blamed; they fear discussion will trigger an eating disorder … Blount disease (tibia vara): Another skeletal disorder associated with childhood obesity.

224. Communication of Weight Classification for Children Who Are Overweight or Obese (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
     February 01, 2020 - they are concerned that parents will feel blamed; and they fear discussion will trigger an eating disorder … Blount disease (tibia vara): Another skeletal disorder associated with childhood obesity.

225. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/policymakers/chipra/overview/background/next-steps3.html
     December 01, 2009 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

226. Opioid Use Among Elderly and Non-Elderly Adults by Socioeconomic Characteristics | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/opioids/data/online-resources/opioids-elderly-nonelderly.html
     February 01, 2024 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

227. Nursing Home Resources | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/es/nursing-home/resources/search.html?page=4
     January 01, 2022 - Trauma Checklist for Long Term Care This worksheet supplements the Primary Care Post Traumatic Stress Disorder

228. AHRQ Announces Funding Available for Expanding Access to Care for People With Long COVID | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/859.html
     April 01, 2023 - Opportunities to increase well-child care engagement for families affected by maternal opioid use disorder

229. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
     March 01, 2015 - Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents Measure Developer: National Collaborative for Innovation in Quality Measurement As part of the Pediatric Quality Measures Program (PQMP), the Agency for Healthcare R…

230. Spotlight on Pennsylvania -- The National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-pennsylvania-state-snapshot.pdf
     January 01, 2018 - implement electronic screening for developmental delays, autism, attention deficit hyperactivity disorder

231. Equity Focus Recommended in Development and Use of Algorithms in Healthcare | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/883.html
     October 01, 2023 - of screening for UAU, brief intervention for those at risk, and medication therapy for alcohol use disorder

232. AHRQ Grants Policy Notices | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/funding/policies/polnotice/index.html
     April 01, 2024 - Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder … 25/19 Intent to Publish Funding Opportunity Announcement the Management of Opioids and Opioid Use Disorder

233. Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
     May 01, 2018 - antipsychotic use among youth included male sex, public insurance, and a diagnosis of psychosis, tic disorder … , or pervasive development disorder or mental retardation (Olfson, et al., 2006). … However, approximately half of the children receiving antipsychotics have attention deficit disorder

234. National Center for Excellence in Primary Care Research | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/ncepcr/index.html
     Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

235. Nursing Home Resources | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/es/nursing-home/resources/search.html?page=1
     January 01, 2022 - Workers’ Stress In this video, Patricia Watson, PhD, of the National Center for Post Traumatic Stress Disorder

236. CHIPRA 150 Section 6, Antipsychotics Testing Summary (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-metabolic-monitoring-testing-summary.pdf
     December 31, 2015 - CHIPRA 150 Section 6, Antipsychotics Testing Summary Measure Submission Summary Measure Name Metabolic Monitoring for Children and Adolescents on Antipsychotics Measure Number: 0150 NQF ID: NA Collection: NA Set…

237. Recommendations to Improve Children's Health Care Quality Measures | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/policymakers/chipra/pubs/background-2012/backgrndapb.html
     December 01, 2012 - Key: ADHD = attention deficit/hyperactivity disorder; AHRQ = Agency for Healthcare Research and Quality

238. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/policymakers/chipra/overview/background/appendix-b1.html
     December 01, 2009 - Substance Use ADHD Care CC-1 Follow-up care for children prescribed attention-deficit/hyperactivity disorder

239. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
     May 01, 2018 - antipsychotic use among youth included male sex, public insurance, and a diagnosis of psychosis, tic disorder … , or pervasive development disorder or mental retardation (Olfson, et al., 2006).

240. PCMH FAQ and Contact Information | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/ncepcr/research/care-coordination/pcmh/faq.html
     August 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …